{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:42:14Z","timestamp":1761043334342,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.urolonc.2013.01.008","type":"journal-article","created":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T21:29:02Z","timestamp":1363469342000},"page":"35.e9-35.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum levels of 17-\u03b2-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: Results from an Italian biopsy cohort"],"prefix":"10.1016","volume":"32","author":[{"given":"Cosimo","family":"De Nunzio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costantino","family":"Leonardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mauro","family":"Gacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Presicce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabiana","family":"Cancrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Tubaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.01.008_bib1","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2012.02.054","article-title":"International variation in prostate cancer incidence and mortality rate","volume":"61","author":"Center","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib2","first-page":"641","article-title":"Molecular markers for prostatic cancer","volume":"2","author":"Castelli","year":"2010","journal-title":"Front Biosci"},{"key":"10.1016\/j.urolonc.2013.01.008_bib3","doi-asserted-by":"crossref","unstructured":"De Nunzio C, Albisinni S, Presicce F, Lombardo R, Cancrini F, Tubaro A. Serum levels of chromogranin A are not predictive of high grade, poorly differentiated prostate cancer: results from an italian biopsy color. Urol Onc. http:\/\/dx.doi.org\/10.1016\/j.urolonc.2012.07.012. S1078-1439 (12) 00254-2.","DOI":"10.1016\/j.urolonc.2012.07.012"},{"key":"10.1016\/j.urolonc.2013.01.008_bib4","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1002\/cncr.26136","article-title":"Circulating estradiol, but not testosterone, is a significant predictor of high-grade prostate cancer in patients undergoing radical prostatectomy","volume":"117","author":"Salonia","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.urolonc.2013.01.008_bib5","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-11-2799","article-title":"Serum sex steroids depict a nonlinear u-shaped association with high-risk prostate cancer at radical prostatectomy","author":"Salonia","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/j.urolonc.2013.01.008_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.eururo.2008.10.035","article-title":"The evolving role of oestrogens and their receptors in the development and progression of prostate cancer","volume":"55","author":"Bonkhoff","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1517\/17425250802587058","article-title":"Finasteride for prostatic disease: an updated and comprehensive review","volume":"4","author":"De Nunzio","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0022-5347(05)64820-3","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatase in metastatic carcinoma of the prostate","volume":"168","author":"Huggins","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib9","first-page":"505","article-title":"Finasteride, an inibitor of 5-alfareductase, supress prostatic dihydriotestosterone in men with benign prostatic hyperplasia","volume":"74","author":"McConnell","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.urolonc.2013.01.008_bib10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/(SICI)1097-0045(19980615)36:1<49::AID-PROS9>3.0.CO;2-6","article-title":"Workgroup I: rodent models of prostate cancer","volume":"36","author":"Lucia","year":"1998","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.01.008_bib11","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/(SICI)1097-0045(19990701)40:2<115::AID-PROS7>3.0.CO;2-3","article-title":"Estrogen receptor-beta: implications for the prostate gland","volume":"40","author":"Chang","year":"1999","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.01.008_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.10759","article-title":"Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates","volume":"91","author":"Ho","year":"2004","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.urolonc.2013.01.008_bib13","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1677\/JME-07-0053","article-title":"Estrogen action on the prostate gland: a critical mix of endocrine and paracrine signalling","volume":"39","author":"Risbridger","year":"2007","journal-title":"J Mol Endocrinol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib14","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ejca.2008.02.051","article-title":"A potential paradox in prostate adenocarcinoma progression: oestrogen as the initiating driver","volume":"44","author":"Singh","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urolonc.2013.01.008_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9440(10)65160-7","article-title":"Estrogen receptor expression in prostate cancer and premalignant prostatic lesions","volume":"155","author":"Bonkhoff","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.urology.2012.01.068","article-title":"Greater percent free testosterone is associated with high grade prostate cancer in men undergoing prostate biopsy","volume":"80","author":"Albisinni","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2013.01.008_bib17","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.juro.2008.10.163","article-title":"The number of cores positive for high grade prostatic intraepithelial neoplasia on initial biopsy is associated with prostate cancer on second biopsy","volume":"181","author":"De Nunzio","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib18","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/pros.21364","article-title":"Metabolic syndrome is associated with high grade gleason score when prostate cancer is diagnosed on biopsy","volume":"71","author":"De Nunzio","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.01.008_bib19","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-5347(05)64051-7","article-title":"Extended peripheral zone biopsy schemes increase cancer detection rate and minimise variance in prostate specific antigen and age related cancer rates: results of a community multipractice study","volume":"169","author":"Presti","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib20","first-page":"70","article-title":"American Cancer Society Prostate Cancer Advisory Commitee: American Cancer Society guideline for the early detection of prostate cancer: update","volume":"60","author":"Wolf","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2013.01.008_bib21","article-title":"Abdominal obesity as a risk factor for prostate cancer diagnosis and high grade disease: a prospective multi center Italian cohort study","author":"De Nunzio","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib22","first-page":"1025","article-title":"The unceraint relationship between obesity and prostate cancer: an Italian biopsy cohort analysis","volume":"37","author":"De Nunzio","year":"2011","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1196\/annals.1386.027","article-title":"Estrogens and mechanisms of prostate cancer progression","volume":"1089","author":"Carruba","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urolonc.2013.01.008_bib24","article-title":"Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ER\u03b2) in human prostate cancer","author":"Nakamura","year":"2012","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.urolonc.2013.01.008_bib25","first-page":"349","article-title":"Estrogen receptor beta displays cell cycle-dependent expression and regulates the G1 phase through a non-genomic mechanism in prostate carcinoma cells","volume":"30","author":"Hurtado","year":"2008","journal-title":"Cell Oncol"},{"key":"10.1016\/j.urolonc.2013.01.008_bib26","article-title":"Circulating free testosterone is an independent predictor of advanced disease in patients with clinically localized prostate cancer","author":"Schnoeller","year":"2012","journal-title":"World J Urol"},{"issue":"10","key":"10.1016\/j.urolonc.2013.01.008_bib27","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.1210\/jc.2006-0866","article-title":"Seasonal variation of etsradiol, follicle stimulating hormone and dehydroepiandrosterone sulphate in women and men","volume":"91","author":"Biornerem","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.urolonc.2013.01.008_bib28","first-page":"3276","article-title":"Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men","volume":"85","author":"Van den Beld","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913000318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913000318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:07:08Z","timestamp":1761041228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913000318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1078143913000318"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.01.008","relation":{},"ISSN":["1078-1439"],"issn-type":[{"type":"print","value":"1078-1439"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum levels of 17-\u03b2-estradiol are not predictive of prostate cancer diagnosis and aggressiveness: Results from an Italian biopsy cohort","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}